Clinical trial
FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX…
NCT00233818 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00233818 |
|---|---|
| Title | FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent |
| Official title | An Evaluation of Sirolimus-Coated Modified BX VELOCITY Balloon-Expandable Stents for the Treatment of Patients With de Novo Native Coronary Artery Lesions |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Sirolimus-coated Bx VELOCITY Stent |
| Enrollment | 15 |
| Start date | Feb 1, 2000 |
| Completion | Jun 1, 2005 |
| First posted | Oct 6, 2005 |
| Last update posted | Oct 12, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: